Ala. Admin. Code 420, ch. 420-4-1, app III

Current through Register Vol. 43, No. 1, October 31, 2024

Appendix III - Submission Of Clinical Materials By Performing Laboratories

Bacillus anthracis

Botulinum neurotoxin-producing species of Clostridium

Brucella abortus

Brucella melitensis

Brucella suis

Burkholderia mallei

Burkholderia pseudomallei

Campylobacter spp.

Candida auris

Carbapenem-resistant Enterobacteriaceae (CRE)

Carbapenem-resistant Pseudomonas aeruginosa (CRPA)

Carbapenem-resistant Acinetobacter baumannii (CRAB)

Coxiella burnetii

Cryptosporidium spp.

E. coli, shiga-toxin producing

Ebola

Francisella tularensis

Haemophilus influenzae from a normally sterile site

Legionella spp. from a lower respiratory sample

Listeria monocytogenes

Mycobacterium tuberculosis

Naegleria fowleri

Neisseria meningitidis from a normally sterile site Novel Coronaviruses Novel Influenza

Salmonella serotype Typhi

Salmonella spp., non-Typhoidal

Shigella spp.

Streptococcus pneumoniae from a normally sterile site *

Variola (Smallpox virus)

Vibrio spp.

Yersinia pestis

* Submit all CSF isolates. Other isolates from normally sterile sites (e.g., blood, middle ear fluid, joint fluid, or peritoneal fluid) must be non-susceptible to any relevant antibiotics according to current Clinical Laboratory Standards Institute M100 guidance.

Ala. Admin. Code 420, ch. 420-4-1, app III

Adopted by Alabama Administrative Monthly Volume XLII, Issue No. 05, February 29, 2024, eff. 4/14/2024.

Author: Sherri L. Davidson, Ph.D, M.P.H., Sharon Massingale, Ph.D, HCLD/CC(ABB)

Statutory Authority:Code of Ala. 1975, §22-11A-13.